<DOC>
	<DOC>NCT00057395</DOC>
	<brief_summary>To determine the rate of response and the duration of the response following therapy with Aroplatinin patients with advanced solid malignancies.</brief_summary>
	<brief_title>A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description>Primary Objective: - Determine response rate (RR; complete and partial response [CR, PR]) and duration after therapy with Aroplatinâ„¢ in patients with advanced solid malignancies. Secondary Objective: - Determine the safety and tolerability of Aroplatin</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Hepatocellular</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)</mesh_term>
	<criteria>Advanced solid malignancies; Amenable to therapy with DACH platinum agents; Measurable disease (RECIST criteria); ECOG performance score of 02; Adequate hematopoietic, liver and renal function; Adequate cardiac function (maximum of class II, NYHA); Women of childbearing potential must have a negative urine or serum pregnancy test; Signed written informed consent; Subjects must be willing to be followed during the course of treatment/observation and followup. No other active malignancies; No prior therapy with oxaliplatin; No known brain metastases; Active, uncontrolled infection or other serious medical illnesses; Not using or have used any investigational therapy during four weeks before start of protocol treatment.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2004</verification_date>
	<keyword>Esophageal Neoplasms</keyword>
	<keyword>Esophagus Neoplasm</keyword>
	<keyword>Esophagus Cancer</keyword>
	<keyword>Esophageal Cancer</keyword>
	<keyword>Esophageal Tumors</keyword>
	<keyword>Esophagus Tumors</keyword>
	<keyword>Neoplasms, Esophageal</keyword>
	<keyword>Hepatocellular Carcinoma</keyword>
	<keyword>Carcinoma, Hepatocellular</keyword>
	<keyword>Hepatoma</keyword>
	<keyword>Colorectal Neoplasms</keyword>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Colorectal Carcinoma</keyword>
	<keyword>Colorectal Tumor</keyword>
	<keyword>Neoplasms, Colorectal</keyword>
	<keyword>Ovarian Neoplasms</keyword>
	<keyword>Ovary Neoplasms</keyword>
	<keyword>Ovary Cancer</keyword>
	<keyword>Ovary Carcinoma</keyword>
	<keyword>Ovarian Cancer</keyword>
	<keyword>Ovarian Carcinoma</keyword>
	<keyword>Neoplasms, Ovarian</keyword>
	<keyword>Pancreatic Neoplasms</keyword>
	<keyword>Pancreatic Cancer</keyword>
	<keyword>Pancreas Neoplasms</keyword>
	<keyword>Pancreas Cancer</keyword>
	<keyword>Neoplasms, Pancreatic</keyword>
	<keyword>Neoplasms, Pancreas</keyword>
	<keyword>and other solid tumors</keyword>
</DOC>